CCS is a fast growing biotechnology division within the New York Blood Center, that provides an unaffiliated, neutral platform for a wide range of clinical trial needs in the areas of regenerative medicine, cell therapies, transfusion medicine, and related endeavors.
A Conceptual Overview of the Cellular Therapy Supply Chain Pathway
Cellular therapy products are increasingly manufactured using cGMP regulations in clean room facilities and creating a cGMP facility from scratch can be an expensive and time consuming endeavor.
The reoccurring challenge of having to figure out how to budget for and consequently price new service request for therapies, methods or projects that are outside of established practices.
We are proud to congratulate Dr. Beth Shaz, Executive Vice President, Chief Medical and Scientific Officer of NYBC on being named one of Crain’s Notable Women in Healthcare.
Follow our blog for the latest news and insights from our experts to stay at the forefront of the industry.
Comprehensive Cell Solutions™ (CCS) leverages NYBC's strengths of innovation, flexibility, mobility, creativity, and quality.
At every step in the pipeline.
Stay at the forefront of the industry.
Don't see what you're looking for? Please ask!